Ifp Advisors, Inc Acadia Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,681 shares of ACAD stock, worth $46,274. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,681

Previous 1,450 84.9%

Holding current value

$46,274

Previous $26,000 65.38%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$14.62 - $18.42 $17,997 - $22,675	1,231 Added 84.9%	2,681 $43,000
Q1 2024 Jul 30, 2024	BUY	$17.79 - $30.86 $25,795 - $44,747	1,450 New	1,450 $26,000
Q1 2023 Apr 18, 2023	SELL	$16.32 - $20.92 $8,160 - $10,460	-500 Reduced 25.0%	1,500 $28,000
Q4 2022 Feb 07, 2023	SELL	$14.2 - $18.63 $383 - $503	-27 Reduced 1.33%	2,000 $37,000
Q3 2022 Nov 08, 2022	BUY	$14.11 - $18.27 $21,165 - $27,405	1,500 Added 284.63%	2,027 $38,000
Q2 2022 Sep 06, 2022	BUY	$13.01 - $27.22 $6,856 - $14,344	527 New	527 $10,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $6,856 - $14,344	-527 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$20.94 - $27.5 $11,035 - $14,492	527 New	527 $0
Q3 2021 Oct 06, 2021	SELL	$15.78 - $24.77 $2,398 - $3,765	-152 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$19.4 - $27.42 $2,871 - $4,058	-148 Reduced 49.33%	152 $4,000
Q1 2021 Apr 30, 2021	BUY	$25.02 - $54.99 $2,502 - $5,499	100 Added 50.0%	300 $8,000
Q4 2020 Jan 25, 2021	BUY	$41.04 - $56.79 $8,208 - $11,358	200 New	200 $11,000
Q3 2020 Oct 29, 2020	SELL	$36.42 - $57.0 $801 - $1,254	-22 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$39.26 - $52.73 $863 - $1,160	22 New	22 $1,000
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$36.21 - $51.4 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$22.22 - $44.01 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $19,177 - $32,472	-1,186 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$14.32 - $22.92 $10,740 - $17,190	750 Added 172.02%	1,186 $0
Q3 2018 Oct 25, 2018	BUY	$13.03 - $21.81 $1,537 - $2,573	118 Added 37.11%	436 $0
Q2 2018 Aug 07, 2018	SELL	$15.07 - $22.34 $7,806 - $11,572	-518 Reduced 61.96%	318 $0
Q1 2018 Jun 03, 2019	BUY	$22.47 - $32.33 $12,111 - $17,425	539 Added 181.48%	836 $25,000
Q1 2018 May 09, 2018	SELL	$22.47 - $32.33 $12,111 - $17,425	-539 Reduced 64.47%	297 $0
Q4 2017 Jan 24, 2018	SELL	$26.84 - $39.14 $45,144 - $65,833	-1,682 Reduced 66.8%	836 $0
Q3 2017 Oct 30, 2017	BUY	$29.49 - $38.37 $14,007 - $18,225	475 Added 23.25%	2,518 $95,000
Q2 2017 Jun 03, 2019	SELL	N/A	-975 Reduced 32.31%	2,043 $57,000
Q1 2017 Jun 03, 2019	SELL	N/A	-3,091 Reduced 50.6%	3,018 $104,000
Q4 2016 Jun 03, 2019	SELL	N/A	-338 Reduced 5.24%	6,109 $176,000
Q2 2016 Jun 03, 2019	BUY	N/A	6,447	6,447 $209,000

Others Institutions Holding ACAD

# of Institutions

281

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account